Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04828603 · ClinicalTrials.gov registry record
Understanding Allergies and Sensitizations in Healthy and Allergic Individuals
A clinical trial of Allergy, sponsored by Stanford University.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT04828603 is a study of Allergy that is actively recruiting participants, run by Stanford University. The registered enrollment target is 2,500 participants, above the 166-participant average among 15 other Allergy trials with a reported enrollment target (1406% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04828603, a study of Allergy, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to strengthen our ability to accurately diagnose allergies and understand cellular, humoral, genetic components and physiological changes in allergic disease
Conditions Studied
Study Locations (1)
California
- Sean N. Parker Center for Allergy and Asthma Research, Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2007-10 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04828603
The ClinicalTrials.gov registry entry for NCT04828603 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 166-participant average among 15 other Allergy trials with a reported enrollment target (1406% higher). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Allergy appearing as the primary indexed condition, and to 0 interventions.
NCT04828603 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04828603 about?
NCT04828603 is a clinical study titled "Understanding Allergies and Sensitizations in Healthy and Allergic Individuals". The purpose of this study is to strengthen our ability to accurately diagnose allergies and understand cellular, humoral, genetic components and physiological changes in allergic disease
What is the current status of trial NCT04828603?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2007-10. Estimated completion is 2028-12.
What conditions does trial NCT04828603 study?
This clinical trial studies the following conditions: Allergy.
Who is sponsoring clinical trial NCT04828603?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04828603 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allergy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron
RECRUITING · Phase 4
-
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
RECRUITING · Phase 3
-
Childhood Allergy and the Neonatal Environment
ACTIVE NOT RECRUITING
-
Urban Environmental Factors and Childhood Asthma
COMPLETED
-
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
COMPLETED · Phase 2
-
Vitamin D, Steroids, and Asthma in African American Youth
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.